In-vitro fertilisation-embryo-transfer complicates the antenatal diagnosis of placenta accreta spectrum using MRI: a retrospective analysis

Clin Radiol. 2020 Dec;75(12):927-933. doi: 10.1016/j.crad.2020.07.013. Epub 2020 Aug 21.

Abstract

Aim: To evaluate the diagnostic accuracy of magnetic resonance imaging (MRI) for the antenatal diagnosis of placenta accreta spectrum (PAS).

Materials and methods: Data from 95 patients with placenta previa or low-lying placenta who underwent MRI at Osaka University Hospital for the antenatal diagnosis of PAS between January 2013 and December 2018 were reviewed retrospectively. The antenatal MRI signs suggesting PAS were assessed. Patients were divided into two groups depending on whether they were diagnosed with PAS. Factors that affected PAS diagnosis were identified using multivariate analysis.

Results: The diagnostic accuracy of MRI for detecting PAS was as follows: 71.4% sensitivity, 96.4% specificity, and area under the curve (AUC) of 0.839 (95% confidence interval [CI]: 0.73-0.91). The diagnostic accuracy was lower in patients with in-vitro fertilisation with embryo transfer (IVF-ET): 22.2% sensitivity, 93.3% specificity, and AUC=0.578 (95% CI: 0.417-0.724). On multivariate analysis, only IVF-ET showed a significant association with false-positive or -negative MRI diagnosis of PAS (adjusted odds ratio: 26.5; 95% CI: 2.42-289.4; p=0.007).

Conclusion: IVF-ET affects the antenatal diagnosis of PAS using MRI.

MeSH terms

  • Adult
  • Embryo Transfer / adverse effects*
  • Female
  • Fertilization in Vitro / adverse effects*
  • Humans
  • Magnetic Resonance Imaging / methods*
  • Middle Aged
  • Placenta Accreta / diagnostic imaging*
  • Pregnancy
  • Prenatal Diagnosis / methods*
  • Retrospective Studies
  • Risk Factors
  • Sensitivity and Specificity